Pfizer
Susan Cresci Frieling has extensive work experience in the pharmaceutical industry, primarily with Pfizer. Susan started their career at Pfizer in 2000 as a Staffing Consultant at Kenexa and later worked as an HR Consultant at Pfizer (through Kenexa). In 2003, they joined Davita as a Recruiter before returning to Pfizer in 2004 as a Director of Talent Acquisition for North America. From 2012 to 2024, Susan held various leadership positions at Pfizer, including Senior Director of Talent Acquisition and Learning and Development Operations, Senior Director of Global Talent Acquisition Lead for the Americas Region, Senior Director HR Lead, and Senior Director of Global HR Lead for Internal Medicine. Susan also served as the Chief of Staff to the Chief HR Officer and VP of People Experience, Enabling Functions and Chief of Staff to the Chief People Experience Officer. Currently, Susan is the Vice President of Pfizer's Oncology Division.
Susan Cresci Frieling attended Lafayette College from 1995 to 1999, where they earned a Bachelor of Arts degree in Psychology.
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.